Delivery Order SPE2DB20D3103-SPE2DB25FP6N0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,542.74 to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count supply). The contract is firm fixed price with no set-aside designation and is scheduled for completion by August 15, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,195.48 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564731145 - YONSA 125 MG TABLET 120S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, AmerisourceBergen provides a comprehensive range of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,542.74, is for the provision of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 19, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of YONSA 125 MG TABLET 120S, a pharmaceutical product, with a potential value of $8,781.92 and a completion date of March 25, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31,...
- This is a $2,271.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product, with a period of performance through July 2025. The award is not set-aside and represents an open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply YONSA 125 MG TABLET 120S. The contract has a ceiling value of $17,563.84 and a period of performance through October 2, 2024. It is a firm-fixed-price contract without any set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of 4,563,649,467 YONSA 125 MG TABLET 120S. The $8,781.92 contract has a completion date of March 6, 2024. This delivery order is part of a larger single award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 through December 31,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. The delivery order has a ceiling value of $4,390.96 and a completion date of April 26, 2024. This award is associated with a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,542.74 firm fixed-price contract is for the delivery of 4,567,919,131 units of the prescription medication YONSA 125 MG TABLET 120S, with a completion date of May 6, 2025. The contract is not designated as a set-aside and was awarded on April 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,957,350 units of the prescription medication YONSA 125 MG TABLET 120S, with a ceiling value of $2,271.36. The contract is a firm fixed-price, non-set-aside delivery order with a period of performance ending on May 8, 2025. AmerisourceBergen Drug Corp holds a substantial...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6N0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of YONSA 125 mg tablets (120-count units) at a ceiling value of $4,542.74. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. YONSA is a prescription medication used in oncology treatment, reflecting the broad pharmaceutical portfolio that AmerisourceBergen supplies to federal medical procurement programs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen leverages this prime IDC to supply brand-name and generic medications, specialty drugs, vaccines, and medical supplies across multiple therapeutic domains to military healthcare systems, the Defense Health Agency, the U.S. Coast Guard, and other government healthcare organizations worldwide. The company's consistent receipt of competitively awarded, non-set-aside contracts demonstrates its capability to meet federal procurement standards for specialized pharmaceutical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 7/25/25 |